Targeting BRD4 bromodomains and beyond: exploring new therapeutic frontiers

56

Targeting BRD4 bromodomains and beyond: exploring new therapeutic frontiers

Tags:

Previous Article

Shaping the cancer epigenome with structural variation

BRD4 bromodomain targeting for new therapeutic frontiers

Related Posts

Unbalanced chromatin binding of Polycomb complexes drives neurodevelopmental disorders

Unbalanced chromatin binding of Polycomb complexes driv...

42

ALS-associated RNA-binding proteins promote UNC13A transcription through REST downregulation

ALS-associated RNA-binding proteins promote UNC13A tran...

133

Hallmarks of liver cancer: Therapeutic implications

Hallmarks of liver cancer: Therapeutic implications

255